The Roles of PCSK9 in Alzheimer’s Disease: A Systematic Review of Clinical, Genetic, and Preclinical Evidence

Alzheimer’s disease (AD) is increasingly associated with alterations in cholesterol metabolism. Proprotein convertase subtilisin/kexin type 9 (PCSK9), an enzyme regulating low-density lipoprotein receptor (LDLR) degradation, has been implicated in AD through mechanisms involving amyloid-β (Aβ) proce...

Descripció completa

Dades bibliogràfiques

Autors principals:	Vicko Suswidiantoro, Meidi Utami Puteri, Mitsuyasu Kato, Donna Maretta Ariestanti, Richard Johari James, Fadlina Chany Saputri
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2025-12-01
Col·lecció:	Life
Matèries:	Alzheimer’s disease amyloid-β cholesterol neurodegeneration PCSK9
Accés en línia:	https://www.mdpi.com/2075-1729/15/12/1851
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!